Alpha Centric Advisors LLC Deciphera Pharmaceuticals, Inc. Transaction History

Alpha Centric Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$13.58 - $17.36 $814,800 - $1.04 Million	60,000 New	60,000 $943,000
Q3 2023 Nov 13, 2023	BUY	$12.46 - $15.48 $679,070 - $843,660	54,500 Added 70.32%	132,000 $1.68 Million
Q2 2023 Aug 08, 2023	BUY	$13.28 - $15.96 $66,400 - $79,800	5,000 Added 6.9%	77,500 $1.09 Million
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $1.03 Million - $1.6 Million	72,500 New	72,500 $1.12 Million
Q3 2020 Mar 11, 2022	SELL	$43.8 - $58.16 $8,760 - $11,632	-200 Closed	0 $0
Q2 2020 Mar 11, 2022	BUY	$37.05 - $65.03 $7,409 - $13,006	200 New	200 $12,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.